期刊文献+

术前B型利钠肽水平预测冠状动脉旁路移植术后新发心房颤动准确性的系统评价 被引量:2

Accuracy of Preoperative B-type Natriuretic Peptide Level in Predicting New Onset Atrial Fibrillation in Patients after Coronary Artery Bypass Grafting:A Systematic Review
原文传递
导出
摘要 目的评价术前B型利钠肽(brain natriuretic peptide,BNP)水平在预测冠状动脉旁路移植术(coronary artery bypass grafting,CABG)后新发心房颤动(atrial fibrillation,AF)中的价值。方法计算机检索PubMed、EMbase、Cochrane图书馆、中国期刊全文数据库(CNKI)及维普(VIP)数据库,筛选有关CABG术前BNP与术后AF发生相关性的文献,检索时间从建库至2012年11月。根据诊断性试验准确性质量评价(QUADAS)标准评价纳入文献质量。采用RevMan 5.0进行异质性检验,Meta-Disc1.4进行Meta分析,对纳入文献进行加权定量合并,计算汇总敏感度、特异度、诊断比值比、阳性似然比和阴性似然比及其95%可信区间(95%CI),绘制汇总受试者工作特征曲线(SROC),并计算ROC曲线下面积(AUC)。结果检出相关文献236篇,根据纳入标准最终纳入5篇文献;共纳入患者802例,其中术后发生AF 228例,未发生AF 574例。纳入文献质量均较高。术前增加的BNP浓度与术后AF发生的诊断比值比为4.15[95%CI(2.90,5.95)];汇总敏感度为0.78[95%CI(0.72,0.83)],汇总特异度为0.58[95%CI(0.54,0.58)],汇总阳性似然比为1.91[95%CI(1.42,1.56)],汇总阴性似然比为0.42[95%CI(0.32,0.54)];AUC为0.79(Q值为0.72)。结论 CABG术前BNP水平升高与术后新发AF具有明显的相关性,是术后AF发生的强预测因子,可以在一定程度上预测术后AF的发生。 Objective To evaluate the value of preoperative B-type natriuretic peptide (BNP) level in predicting new onset atrial fibrillation (AF) in patients after coronary artery bypass grafting (CABG). Methods We electronically searched PubMed, EMbase, Cochrane Library, CNKI and VIP databases from the establishment of those databases to November 2012. Evaluation standard of diagnostic tests was used to identify and screen literatures which investigated correlations between preoperative BNP levels and new onset AF of patients after CABG. Quality Assessment of Diagnostic Accuracy Studies (QUADAS) was used to evaluate study quality of included literatures. RevMan 5.0 was used for heterogeneity test. Meta-Disc 1.4 software was used for meta-analysis. Included studies were weighted and then combined. Sensitivity, specificity, diag- nostic odds ratio (DOR), positive likelihood ratio, negative likelihood ratio and corresponding 95% confidence interval( 95% CI) were calculated. Summary receiver operating characteristic (SROC) curve was drawn, and the area under the SROC curve (AUC) was analyzed. Results A total of 236 studies were identified, and 5 studies met the eligibility criteria including 802 patients for analysis. There were 228 patients with postoperative new onset AF, and 574 patients without postoperative AF. The quality of the included literature was relatively high. DOR of preoperative elevated BNP level with postoperative new onset AF was 4.15 with 95% CI 2.90 to 5.95. Pooled sensitivity was 0.78 with 95% CI 0.72 to 0.83, pooled specificity was 0.58 with 95% CI 0.54 to 0.58, pooled positive likelihood ratio was 1.91 with 95% CI 1.42 to 1.56, pooled negative likelihood ratio was 0.42 with 95% CI 0.32 to 0.54, and the AUC of SROC was 0.79 (Q=0.72). Conclusion Preoperative elevated BNP level is significantly correlated with new onset AF after CABG, is a powerful predictor of post- operative AF, and can be used to predict new onset AF after CABG to a certain extent of reliability.
出处 《中国胸心血管外科临床杂志》 CAS 2013年第4期381-386,共6页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 中华医学会胸心血管外科分会厄尔巴肯科研奖学金(2011-H28#) 中央级公益性科研院所基本科研业务费资助项目(2012-F14)~~
关键词 B型利钠肽 冠状动脉旁路移植术 心房颤动 B-type natriuretic peptide Coronary artery bypass grafting Atrial fibrillation
  • 相关文献

参考文献30

  • 1Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA, 1996, 276: 300-306.
  • 2Usta E, Mustafi M, Walker T, et al. Resveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation. J Cardiovasc Surg (Torino), 2011, 52 ( 3 ) : 399-409.
  • 3Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibril- lation after coronary artery surgery. Current trends and impact on hospital resources.Circulation, 1996, 94: 390-397.
  • 4Wang Z, Liang D, Fu Q, et al. Perioperative brain natriuretic peptide in off-pump coronary artery bypass. Acta Cardiol, 2010, 65 (3): 297-301.
  • 5Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriu- retic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coil Cardiol, 2004, 43 (10): 1873-1879.
  • 6Sachdeva A, Horwich TB, Fonarow GC. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol, 2010, 106 (6): 830-835.
  • 7Fellahi JL, Daceache G, Rubes D, et al. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery ? J Cardiothorae Vase Anesth, 2011, 25(2): 256-262.
  • 8Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 2003, 3: 25.
  • 9Krzych L J, Szurlej D, Kooldziej T, et al. Diagnostic accuracy of pre-operative NT-proBNP level in predicting short-term outcomes in coronary surgery:Apilot study. Kardiol Pol, 2011, 69: 1121-1127.
  • 10Ata Y, Turk T, Ay D, et al. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Heart Surg Forum, 2009, 12 (4): E211-E216.

二级参考文献16

  • 1Gardner RS, Chong KS, Murday AJ, et al. N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation. Heart, 2006,92(1): 121-123.
  • 2Sartipy U, Albage A, Larsson PT, et al. Changes in B-type natriuretie peptides after surgical ventricular restoration. Eur J Cardiothorac Surg, 2007,31(5) :922-928.
  • 3Walsh R, Boyer C, LaCorte J, et al. N-terminal B-type natriuretie peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery. J Thorae Cardiovasc Surg, 2008,135(1):98-105.
  • 4Dodge-Khatami A, Buchel EV, Knirseh W, et al. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. Ann Thorac Surg, 2006, 82 (3) :983-988.
  • 5Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoraeic surgery. N Engl J Med, 1997, 336 (20) : 1429- 1434.
  • 6Cosgrave J, Foley JB, MeGovern E, et al. Brain natriuretic peptide elevation and the development of atrial fibrillation following coronary artery bypass surgery. Interact Cardiovasc Thorac Surg, 2006, 5(2) :111-114.
  • 7Huang SC, Wu ET, Ko WJ, et al. Clinical implication of blond levels of B-type natriuretic peptide in pediatric patients on mechanical circulatory support. Ann Thorac Surg, 2006, 81(6): 2267-2272.
  • 8Fox AA, Shernan SK, Collard CD, et al. Preoperative B-type natriuretic peptide is as independent predietor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. J Thorae Cardiovasc Surg, 2008, 136(2):452-461.
  • 9Januzzi JL, Morss A, Tung R, et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective conort study. Crit Care,2006, 10(1): R37.
  • 10Watanabe I, Tani S, Washio T, etal. Relationship between the plasma levels of brain natriuretic peptide and left ventricular ejection fraction in asymptomatic patients with previous myocardial infarction. Int Heart J,2005,46(6) :1007-1014.

共引文献5

同被引文献22

  • 1史晓敏,林箐,徐国宾,宋以信,夏铁安.血清N末端B型钠尿肽原在心功能评价及慢性充血性心力衰竭诊断中的初步应用[J].中华检验医学杂志,2005,28(1):37-41. 被引量:76
  • 2史晓敏,徐国宾,夏铁安,王宏伟.人血清N末端B型钠尿肽原参考值调查[J].诊断学理论与实践,2005,4(4):291-295. 被引量:19
  • 3潘柏申,蔡乃绳,李清,范维琥,李勇,郭玮,周琰,陶青.表面健康人群氨基末端B型利钠肽参考范围调查[J].中华检验医学杂志,2006,29(1):23-26. 被引量:65
  • 4Lawrie CH,Gal S,Dunlop HM, et al. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J]. Br J Haematol,2008,141(4) :672-675.
  • 5Cai E H,Gao YX, Wei ZZ, et al. Serum miR-21 expression in hu- man esophageal squamous cell carcinomas[J]. Asian Pac J Cancer Prev, 2012,13(4) : 1563-1567.
  • 6Komatsu S, Ichikawa D, Takeshita H, et al. Circulating microR- NAs in plasma of patients with oesophageal squamous cell carci- noma[J]. Br J Cancer,2011,105(1) : 104-111.
  • 7Xie Z, Chen G, Zhang X, et al. Salivary microRNAs as promising biomarkers for detection of esophageal cancer[J]. PLoS One, 2013,8(4) : e57502.
  • 8Wang B,Zhang Q. The expression and clinical significance of cir- culating mieroRNA-21 in serum of five solid tumors[J]. J Cancer Res Clin Oneol,2012,138(10): 1659-1666.
  • 9Xie ZJ,Chen G,Zhang XC,et al. Saliva supernatant miR-21 :a no- vel potential biomarker for esophageal cancer detection[J]. Asian Pac J Cancer Prev,2012,13(12) :6145-6149.
  • 10Krol J, Loedige I,Filipowicz W. The widespread regulation of mi-croRNA biogenesis, function and decay[J]. Nat Rev Genet, 2010, 11(9) :597-610,.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部